IntegraGen, a France-based developer of genetic tests for complex diseases, has raised Euro 2 million in funding from DSM Venturing, the corporate venturing arm of Royal DSM NV. www.integragen.com
IntegraGen, a France-based developer of genetic tests for complex diseases, has raised Euro 2 million in funding from DSM Venturing, the corporate venturing arm of Royal DSM NV. www.integragen.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: